We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Firefly Neuroscience Inc (AIFF) USD0.001

Sell:$3.14 Buy:$3.15 Change: $1.25 (65.79%)
Market closed |  Prices as at close on 14 January 2025 | Switch to live prices |
Sell:$3.14
Buy:$3.15
Change: $1.25 (65.79%)
Market closed |  Prices as at close on 14 January 2025 | Switch to live prices |
Sell:$3.14
Buy:$3.15
Change: $1.25 (65.79%)
Market closed |  Prices as at close on 14 January 2025 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder (ADHD). BNA, utilizing AI and an extensive proprietary electroencephalogram (EEG) database, combines the automatic analysis of Event Related Potentials (ERPs), spectral EEG and behavioral performance data for a comprehensive, and objective data-driven brain health evaluation. The BNA Platform, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function (cognition).

Contact details

Address:
1100 Military Road
KENMORE
14217
United States
Telephone:
+ ()
Website:
https://fireflyneuro.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
AIFF
ISIN:
US3179701012
Market cap:
$16.16 million
Shares in issue:
8.50 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • David Johnson
    Executive Chairman of the Board
  • Samer Kaba
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.